COMMUNIQUÉS West-GlobeNewswire

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
29/07/2026
TEL AVIV, Israel, July 29, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Rose Hill Life Sciences Appoints Bryan Smith as Scientific Advisor
29/07/2026
Veteran Drug Discovery Executive Brings Nearly Two Decades of Oncology and Translational Research Leadership to Advance Rose Hill’s Clinical Pipeline BOSTON, July 29, 2026 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences (“ [...]
Walmart Canada, Associates and Customers Raise $7.2 Million to Support Children’s Hospitals Across Canada
29/07/2026
MISSISSAUGA, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- Walmart Canada, associates and customers came together once again this spring, raising $7.2 million to support children’s hospital foundations across the country. [...]
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
29/07/2026
DURHAM, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for [...]
Acentra Health Names Srini Surendranath as Senior Vice President of Product and Solutions Management
29/07/2026
New leadership role strengthens product innovation and solutions strategy to accelerate growth and deliver greater value for clients MCLEAN, Va., July 29, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
29/07/2026
--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Primary Endpoint, with [...]
ACTG to Make Three Presentations on HIV Cure and Aging with HIV at AIDS 2026
29/07/2026
CHAPEL HILL, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced today that it will make three presentations at AIDS 2026 , which is [...]
RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
29/07/2026
MOUNTAIN VIEW, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing [...]
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
29/07/2026
MIRAMAR, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to [...]
TimelyCare Sets New Standard for Student Safety with URAC Artificial Intelligence in Healthcare Accreditation
29/07/2026
Independent review validates the governance, safeguards and accountability supporting TimelyCare’s responsible use of AI Fort Worth, TX, July 29, 2026 (GLOBE NEWSWIRE) -- Prioritizing student safety and well-being in [...]
LB Pharmaceuticals Announces $150 Million Private Placement
29/07/2026
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
29/07/2026
Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company’s shareholders Fiscal 2026 saw the full commercial launch of the MyoVista [...]
Alvotech announces successful closure of FDA inspection of manufacturing facility
29/07/2026
REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
Angelman Syndrome Foundation and Citizen Health Partner to Put Advanced AI to Work for Every Angelman Family
29/07/2026
Citizen Health's AI advocate for rare disease families debuts for the Angelman community at the 2026 ASF Family Conference SAN FRANCISCO and DENVER, July 29, 2026 (GLOBE NEWSWIRE) -- The Angelman Syndrome Foundation ( [...]
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
29/07/2026
PDUFA target action date of November 28, 2026, approximately one quarter ahead of Company’s previously communicated guidance FDA identified no Filing review issues Acceptance triggers $15 million milestone payment, [...]
Realize Medical Appoints Chris Marrus to Board of Directors
29/07/2026
Surgical robotics and medtech commercialization veteran joins Realize Medical's board as the company scales Elucis, its FDA-cleared VR surgical planning platform OTTAWA, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- [...]
PROLLENIUM® Expands PACE with Launch of Eight New Clinical Education Modules
29/07/2026
New modules, developed with Harley Academy, extend the PACE Training & Education Portal across foundational and advanced clinical techniques RICHMOND HILL, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- PROLLENIUM® , a [...]
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France
29/07/2026
July 28, 2026 Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products [...]
Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy
29/07/2026
Q2 2026 revenues of $4.1 billion decreased by 1% in U.S. dollars year-over-year (YoY) and by 3% in local currency (LC) terms, mainly due to lower generics revenues. Our key innovative brands collectively grew 43% YoY in [...]

Pages